首页 › 卵巢癌 › 罗德岛州 › Providence
Providence RI 卵巢癌临床试验
15项针对 卵巢癌的研究正在 Providence及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Women and Infants Hospital, Providence
- Roger Williams Medical Center, Providence
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
招募中1/2 期
- Research Site, Providence
TLR9 Immunotherapy for Peritoneal Carcinomatosis
招募中1 期
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
招募中2 期
- Women & Infants Hospital /ID# 277930, Providence
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
招募中2 期
- Women & Infants Hospital /ID# 274716, Providence
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
招募中3 期
- Women & Infants Hospital, Providence
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
招募中3 期
- Women & Infants Hospital ( Site 0001), Providence
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
招募中3 期
- Women & Infants Hospital ( Site 0050), Providence
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
招募中
- Women and Infants Hospital, Providence
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Women and Infants Hospital, Providence
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- Women and Infants Hospital of Rhode Island, Providence
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- Lifespan Cancer Institute - Rhode Island Hospital, Providence
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
招募中欢迎健康志愿者
- Women's and Infant's Hospital, Providence
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
招募中1 期
- Site 0191, Providence
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Providence
其他城市的 卵巢癌试验
- Houston, TX89 项研究
- New York City, NY69 项研究
- Boston, MA61 项研究
- Los Angeles, CA50 项研究
- Nashville, TN49 项研究
- Arlington, VA46 项研究
- Philadelphia, PA44 项研究
- Columbus, OH39 项研究
- St. Louis, MO38 项研究
- Chicago, IL36 项研究
- San Antonio, TX31 项研究
- Cleveland, OH30 项研究
Providence的其他研究
- 子宫内膜癌14 项研究
- 肥胖症14 项研究
- 非小细胞肺癌12 项研究
- 癌症（所有类型）12 项研究
- 克罗恩病12 项研究
- 乳腺癌11 项研究
- 溃疡性结肠炎11 项研究
- 急性髓系白血病10 项研究
- 转移性癌症9 项研究
- 超重9 项研究
- 酒精使用障碍 (AUD)8 项研究
- 阿尔茨海默病8 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。